DexCom (DXCM) Q2 Earnings and Revenues Top Estimates

分组1 - DexCom reported quarterly earnings of $0.48 per share, exceeding the Zacks Consensus Estimate of $0.45 per share, and showing an increase from $0.43 per share a year ago, representing an earnings surprise of +6.67% [1] - The company achieved revenues of $1.16 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.06%, and up from $1 billion in the same quarter last year [2] - DexCom has outperformed the S&P 500 with a stock increase of about 14.9% since the beginning of the year, compared to the S&P 500's gain of 8.3% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.57 on revenues of $1.18 billion, and for the current fiscal year, it is $2.03 on revenues of $4.61 billion [7] - The Zacks Industry Rank indicates that the Medical - Instruments sector is currently in the bottom 35% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - DexCom holds a Zacks Rank 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6]